Pitavastatin magnesium is an orally active HMG-CoA Reductase inhibitor. Pitavastatin magnesium lowers total cholesterol and low-density lipoprotein cholesterol in a hyperlipidemic rat model. Pitavastatin magnesium can be used in research on cardiovascular and cerebrovascular diseases such as hyperlipidemia [1] [2].
References:
[1]. Pitavastatin magnesium (Zypitamag) for hyperlipidemia. Med Lett Drugs Ther. 2018 Jun 18;60(1549):106.
[2]. Abolhasani S, et al. Pitavastatin-induced cholesterol deficiency elevates serum biomarkers associated with statin-related adverse effects in rats. Cardiovasc Endocrinol Metab. 2025 Mar 7;14(2):e00326.
References:
[1]. Pitavastatin magnesium (Zypitamag) for hyperlipidemia. Med Lett Drugs Ther. 2018 Jun 18;60(1549):106.
[2]. Abolhasani S, et al. Pitavastatin-induced cholesterol deficiency elevates serum biomarkers associated with statin-related adverse effects in rats. Cardiovasc Endocrinol Metab. 2025 Mar 7;14(2):e00326.
















